arcadia biosciences glp-1 receptor agonist weight management diabetes treatments Frontiers How a 'blockbuster' treatment for
Description
Gynecol Endocrinol (2023) 39(1):2181652
GLP1/glucagon dual agonists have furthermore been shown to ameliorate hepatic fat content 4,5 and fibrosis 6 as well as promoting liver regeneration 4
The Diabetes Control and Complications Trial Research Group
It doesnt exclude a whole lot of patients, remembering that the prevalence of medullary thyroid cancer and MEN 2 in the general adult population is somewhere between 1 in 30,000 and 1 in 40,000. Pearce adds that patients and doctors alike should not be unduly concerned by any possible effects on the thyroid
